MAPK/ERK signaling pathway analysis in primary osteoblasts from patients with nonsyndromic sagittal craniosynostosis

Sun Don Kim, Garima Yagnik, Michael L. Cunningham, Jinoh Kim, Simeon Boyd

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective: The MAPK/ERK signaling pathway has been implicated in several craniosynostosis syndromes and represents a plausible target for therapeutic management of craniosynostosis. The causes of sagittal nonsyndromic craniosynostosis (sNSC) have not been well understood and the role that MAPK/ERK signaling cascade plays in this condition warrants an investigation. We hypothesized that MAPK-signaling is misregulated in calvarial osteoblasts derived from patients with sNSC. Methods: In order to analyze if the MAPK/ERK pathway is perturbed in sNSC, we established primary calvarial osteoblast cell lines from patients undergoing surgery for correction of this congenital anomaly. Appropriate negative and positive control cell lines were used for comparison, and we examined the levels of phosphorylated ERK by immunoblotting. Results: Primary osteoblasts from patients with sNSC showed no difference in ERK1/2 phosphorylation with or without FGF2 stimulation as compared with control osteoblasts. Conclusion: Under the described test conditions, we did not observe convincing evidence that MAPK/ERK signaling contributes to the development of sNSC.

Original languageEnglish (US)
Pages (from-to)115-119
Number of pages5
JournalCleft Palate-Craniofacial Journal
Volume51
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Craniosynostoses
MAP Kinase Signaling System
Osteoblasts
Cell Line
Fibroblast Growth Factor 2
Immunoblotting
Phosphorylation

Keywords

  • BFGF
  • ERK
  • FGF2
  • FGFRs
  • MAPK
  • Non-syndromic
  • Nonsyndromic
  • Sagittal craniosynostosis

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Oral Surgery

Cite this

MAPK/ERK signaling pathway analysis in primary osteoblasts from patients with nonsyndromic sagittal craniosynostosis. / Kim, Sun Don; Yagnik, Garima; Cunningham, Michael L.; Kim, Jinoh; Boyd, Simeon.

In: Cleft Palate-Craniofacial Journal, Vol. 51, No. 1, 01.2014, p. 115-119.

Research output: Contribution to journalArticle

Kim, Sun Don ; Yagnik, Garima ; Cunningham, Michael L. ; Kim, Jinoh ; Boyd, Simeon. / MAPK/ERK signaling pathway analysis in primary osteoblasts from patients with nonsyndromic sagittal craniosynostosis. In: Cleft Palate-Craniofacial Journal. 2014 ; Vol. 51, No. 1. pp. 115-119.
@article{485fe791e4774e6cbfea810e90b66755,
title = "MAPK/ERK signaling pathway analysis in primary osteoblasts from patients with nonsyndromic sagittal craniosynostosis",
abstract = "Objective: The MAPK/ERK signaling pathway has been implicated in several craniosynostosis syndromes and represents a plausible target for therapeutic management of craniosynostosis. The causes of sagittal nonsyndromic craniosynostosis (sNSC) have not been well understood and the role that MAPK/ERK signaling cascade plays in this condition warrants an investigation. We hypothesized that MAPK-signaling is misregulated in calvarial osteoblasts derived from patients with sNSC. Methods: In order to analyze if the MAPK/ERK pathway is perturbed in sNSC, we established primary calvarial osteoblast cell lines from patients undergoing surgery for correction of this congenital anomaly. Appropriate negative and positive control cell lines were used for comparison, and we examined the levels of phosphorylated ERK by immunoblotting. Results: Primary osteoblasts from patients with sNSC showed no difference in ERK1/2 phosphorylation with or without FGF2 stimulation as compared with control osteoblasts. Conclusion: Under the described test conditions, we did not observe convincing evidence that MAPK/ERK signaling contributes to the development of sNSC.",
keywords = "BFGF, ERK, FGF2, FGFRs, MAPK, Non-syndromic, Nonsyndromic, Sagittal craniosynostosis",
author = "Kim, {Sun Don} and Garima Yagnik and Cunningham, {Michael L.} and Jinoh Kim and Simeon Boyd",
year = "2014",
month = "1",
doi = "10.1597/12-136",
language = "English (US)",
volume = "51",
pages = "115--119",
journal = "Cleft Palate-Craniofacial Journal",
issn = "1055-6656",
publisher = "American Cleft Palate Craniofacial Association",
number = "1",

}

TY - JOUR

T1 - MAPK/ERK signaling pathway analysis in primary osteoblasts from patients with nonsyndromic sagittal craniosynostosis

AU - Kim, Sun Don

AU - Yagnik, Garima

AU - Cunningham, Michael L.

AU - Kim, Jinoh

AU - Boyd, Simeon

PY - 2014/1

Y1 - 2014/1

N2 - Objective: The MAPK/ERK signaling pathway has been implicated in several craniosynostosis syndromes and represents a plausible target for therapeutic management of craniosynostosis. The causes of sagittal nonsyndromic craniosynostosis (sNSC) have not been well understood and the role that MAPK/ERK signaling cascade plays in this condition warrants an investigation. We hypothesized that MAPK-signaling is misregulated in calvarial osteoblasts derived from patients with sNSC. Methods: In order to analyze if the MAPK/ERK pathway is perturbed in sNSC, we established primary calvarial osteoblast cell lines from patients undergoing surgery for correction of this congenital anomaly. Appropriate negative and positive control cell lines were used for comparison, and we examined the levels of phosphorylated ERK by immunoblotting. Results: Primary osteoblasts from patients with sNSC showed no difference in ERK1/2 phosphorylation with or without FGF2 stimulation as compared with control osteoblasts. Conclusion: Under the described test conditions, we did not observe convincing evidence that MAPK/ERK signaling contributes to the development of sNSC.

AB - Objective: The MAPK/ERK signaling pathway has been implicated in several craniosynostosis syndromes and represents a plausible target for therapeutic management of craniosynostosis. The causes of sagittal nonsyndromic craniosynostosis (sNSC) have not been well understood and the role that MAPK/ERK signaling cascade plays in this condition warrants an investigation. We hypothesized that MAPK-signaling is misregulated in calvarial osteoblasts derived from patients with sNSC. Methods: In order to analyze if the MAPK/ERK pathway is perturbed in sNSC, we established primary calvarial osteoblast cell lines from patients undergoing surgery for correction of this congenital anomaly. Appropriate negative and positive control cell lines were used for comparison, and we examined the levels of phosphorylated ERK by immunoblotting. Results: Primary osteoblasts from patients with sNSC showed no difference in ERK1/2 phosphorylation with or without FGF2 stimulation as compared with control osteoblasts. Conclusion: Under the described test conditions, we did not observe convincing evidence that MAPK/ERK signaling contributes to the development of sNSC.

KW - BFGF

KW - ERK

KW - FGF2

KW - FGFRs

KW - MAPK

KW - Non-syndromic

KW - Nonsyndromic

KW - Sagittal craniosynostosis

UR - http://www.scopus.com/inward/record.url?scp=84892385072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892385072&partnerID=8YFLogxK

U2 - 10.1597/12-136

DO - 10.1597/12-136

M3 - Article

VL - 51

SP - 115

EP - 119

JO - Cleft Palate-Craniofacial Journal

JF - Cleft Palate-Craniofacial Journal

SN - 1055-6656

IS - 1

ER -